IWM
IRWD icon

IHT Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

IHT Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60
Closed -$784 – 1733
2017
Q3 		$1K Buy
+60
New +$826 ﹤0.01% 1320

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IHT Wealth Management's IRWD Position: Q4 2017 in Review

IHT Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 60 shares — an estimated $784 sold.

IHT Wealth Management first reported a position in IRWD in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

  • IHT Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • IHT Wealth Management sold 60 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $784.
  • IHT Wealth Management first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • IHT Wealth Management's Ironwood Pharmaceuticals position peaked at $1K in Q3 2017.
  • 158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on IHT Wealth Management's 13F filing for Q4 2017, filed 14 Feb 2018.